These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 3265676

  • 1. Interleukin-5: an eosinophil growth and activation factor.
    Sanderson CJ.
    Dev Biol Stand; 1988; 69():23-9. PubMed ID: 3265676
    [Abstract] [Full Text] [Related]

  • 2. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays.
    Clutterbuck E, Shields JG, Gordon J, Smith SH, Boyd A, Callard RE, Campbell HD, Young IG, Sanderson CJ.
    Eur J Immunol; 1987 Dec; 17(12):1743-50. PubMed ID: 3500861
    [Abstract] [Full Text] [Related]

  • 3. The Mpl-ligand is involved in the growth-promoting activity of the murine stromal cell line MS-5 on ES cell-derived hematopoiesis.
    Mitjavila MT, Filippi MD, Cohen-Solal K, Le Pesteur F, Vainchenker W, Sainteny F.
    Exp Hematol; 1998 Feb; 26(2):124-34. PubMed ID: 9472802
    [Abstract] [Full Text] [Related]

  • 4. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J, Mueller G, Zaiss M, Kunz-Schughart LA, Andreesen R, Hennemann B.
    Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human interleukin 5 is a selective eosinophil chemoattractant.
    Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A.
    Eur J Immunol; 1989 Apr; 19(4):701-5. PubMed ID: 2659368
    [Abstract] [Full Text] [Related]

  • 7. Synergistic interaction of hematopoietic colony stimulating and growth factors in the regulation of myelopoiesis.
    Broxmeyer HE, Williams DE, Cooper S, Ralph P, Gillis S, Bicknell DC, Hangoc G, Drummond R, Lu L.
    Behring Inst Mitt; 1988 Aug; (83):80-4. PubMed ID: 3266466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR.
    Stem Cells; 1997 Aug; 15(1):63-72. PubMed ID: 9007224
    [Abstract] [Full Text] [Related]

  • 13. Culture and characterization of hematopoietic progenitor cells from miniature swine.
    Emery DW, Sachs DH, LeGuern C.
    Exp Hematol; 1996 Jul; 24(8):927-35. PubMed ID: 8690052
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 15. Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation.
    Koyama N, Harada N, Takahashi T, Mita S, Okamura H, Tominaga A, Takatsu K.
    Immunology; 1988 Feb; 63(2):277-83. PubMed ID: 3280472
    [Abstract] [Full Text] [Related]

  • 16. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M, Tocci A, Gabbianelli M, Luchetti L, Masella B, Vitelli L, Botta R, Testa U, Condorelli GL, Peschle C.
    Cancer Res; 1998 Feb 01; 58(3):562-9. PubMed ID: 9458106
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL, Ponzio NM, Thorbecke GJ.
    J Immunol; 1988 Jan 15; 140(2):679-87. PubMed ID: 3275720
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.